179 related articles for article (PubMed ID: 2522816)
1. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.
Steck PA; Moser RP; Bruner JM; Liang L; Freidman AN; Hwang TL; Yung WK
Cancer Res; 1989 Apr; 49(8):2096-103. PubMed ID: 2522816
[TBL] [Abstract][Full Text] [Related]
2. Adhesion defective BHK cell mutant has cell surface heparan sulfate proteoglycan of altered properties.
Couchman JR; Austria R; Woods A; Hughes RC
J Cell Physiol; 1988 Aug; 136(2):226-36. PubMed ID: 2970466
[TBL] [Abstract][Full Text] [Related]
3. Hormonal modification of epithelial differentiation and expression of cell surface heparan sulfate proteoglycan in the mouse vaginal epithelium. An immunohistochemical and electron microscopic study.
Hayashi K; Hayashi M; Boutin E; Cunha GR; Bernfield M; Trelstad RL
Lab Invest; 1988 Jan; 58(1):68-76. PubMed ID: 2961930
[TBL] [Abstract][Full Text] [Related]
4. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin.
Vallen EA; Eldridge KA; Culp LA
J Cell Physiol; 1988 May; 135(2):200-12. PubMed ID: 2967301
[TBL] [Abstract][Full Text] [Related]
8. Visualization of the large heparan sulfate proteoglycan from basement membrane.
Laurie GW; Inoue S; Bing JT; Hassell JR
Am J Anat; 1988 Mar; 181(3):320-6. PubMed ID: 2452565
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycan expression in normal human liver.
Roskams T; Moshage H; De Vos R; Guido D; Yap P; Desmet V
Hepatology; 1995 Apr; 21(4):950-8. PubMed ID: 7705805
[TBL] [Abstract][Full Text] [Related]
10. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of glycosaminoglycans in cultures of human, normal and malignant glial cells.
Glimelius B; Norling B; Westermark B; Wasteson A
J Cell Physiol; 1979 Mar; 98(3):527-37. PubMed ID: 438297
[TBL] [Abstract][Full Text] [Related]
12. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells.
Schrappe M; Klier FG; Spiro RC; Waltz TA; Reisfeld RA; Gladson CL
Cancer Res; 1991 Sep; 51(18):4986-93. PubMed ID: 1893386
[TBL] [Abstract][Full Text] [Related]
13. Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans.
Stevens RL; Lee TD; Seldin DC; Austen KF; Befus AD; Bienenstock J
J Immunol; 1986 Jul; 137(1):291-5. PubMed ID: 3086452
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of chondroitin and heparan sulfate proteoglycans in pre-spina bifida splotch mouse embryos.
Trasler DG; Morriss-Kay G
Teratology; 1991 Nov; 44(5):571-9. PubMed ID: 1771598
[TBL] [Abstract][Full Text] [Related]
15. Components of subendothelial aorta basement membrane. Immunohistochemical localization and role in cell attachment.
Palotie A; Tryggvason K; Peltonen L; Seppä H
Lab Invest; 1983 Sep; 49(3):362-70. PubMed ID: 6224965
[TBL] [Abstract][Full Text] [Related]
16. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
17. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans synthesized by cultured bovine corneal endothelial cells.
Robinson J; Gospodarowicz D
J Cell Physiol; 1983 Dec; 117(3):368-76. PubMed ID: 6418749
[TBL] [Abstract][Full Text] [Related]
19. Isolation of the heparan sulfate proteoglycans from the extracellular matrix of rat skeletal muscle.
Brandan E; Inestrosa NC
J Neurobiol; 1987 May; 18(3):271-82. PubMed ID: 2955079
[TBL] [Abstract][Full Text] [Related]
20. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
